Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans

被引:111
作者
Haneberg, B
Dalseg, R
Wedege, E
Hoiby, EA
Haugen, IL
Oftung, F
Andersen, SR
Naess, LM
Aase, A
Michaelsen, TE
Holst, J
机构
[1] Natl Inst Hlth, Dept Vaccinol, N-0403 Oslo, Norway
[2] Natl Inst Hlth, Dept Bacteriol, N-0403 Oslo, Norway
关键词
D O I
10.1128/IAI.66.4.1334-1341.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A nasal vaccine, consisting of outer membrane vesicles (OMVs) from group B Neisseria meningitidis, was given to 12 volunteers in the form of nose drops or nasal spray four times at weekly intervals, with a fifth dose 5 months later, Each nasal dose consisted of 250 mu g of protein, equivalent to 10 times the intramuscular dose that was administered twice with a 6-week interval to 11 other volunteers. All individuals given the nasal vaccine developed immunoglobulin A (IgA) antibody responses to OMVs in nasal secretions, and eight developed salivary IgA antibodies which persisted for at least 5 months, Intramuscular immunizations did not lead to antibody responses in the secretions. Modest increases in serum IgG antibodies were obtained in 5 volunteers who had been immunized intranasally, while 10 individuals responded strongly to the intramuscular vaccine. Both the serum and secretory antibody responses reached a maximum after two to three doses of the nasal vaccine, with no significant booster effect of the fifth dose, The pattern of serum antibody specificities against the different OMV components after intranasal immunizations was largely similar to that obtained with the intramuscular vaccine. Five and eight vaccinees in the nasal group developed persistent increases in serum bactericidal titers to the homologous meningococcal vaccine strain expressing low and high levels, respectively, of the outer membrane protein Ope. Our results indicate that meningococcal OMVs possess the structures necessary to initiate systemic as well as local mucosal immune responses when presented as a nasal vaccine. Although the serum antibody levels were less conspicuous than those after intramuscular vaccinations, the demonstration of substantial bactericidal activity indicates that a nonproliferating nasal vaccine might induce antibodies of high functional quality.
引用
收藏
页码:1334 / 1341
页数:8
相关论文
共 31 条
  • [1] AABERGE IS, 1995, J CELL BIOCH A S, V19, P242
  • [2] Intranasal booster vaccination against diphtheria and tetanus in man
    Aggerbeck, H
    Gizurarson, S
    Wantzin, J
    Heron, I
    [J]. VACCINE, 1997, 15 (03) : 307 - 316
  • [3] Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina
    Bergquist, C
    Johansson, EL
    Lagergard, T
    Holmgren, J
    Rudin, A
    [J]. INFECTION AND IMMUNITY, 1997, 65 (07) : 2676 - 2684
  • [4] Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate
    Bergquist, C
    Lagergard, T
    Holmgren, J
    [J]. INFECTION AND IMMUNITY, 1997, 65 (05) : 1579 - 1583
  • [5] Berstad AKH, 1997, VACCINE, V15, P1473
  • [6] EFFECT OF OUTER-MEMBRANE VESICLE VACCINE AGAINST GROUP-B MENINGOCOCCAL DISEASE IN NORWAY
    BJUNE, G
    HOIBY, EA
    GRONNESBY, JK
    ARNESEN, O
    HOLSTFREDRIKSEN, J
    HALSTENSEN, A
    HOLTEN, E
    LINDBAK, AK
    NOKLEBY, H
    ROSENQVIST, E
    SOLBERG, LK
    CLOSS, O
    ENG, J
    FROHOLM, LO
    LYSTAD, A
    BAKKETEIG, LS
    HAREIDE, B
    [J]. LANCET, 1991, 338 (8775) : 1093 - 1096
  • [7] HUMORAL IMMUNE-RESPONSE PATTERNS OF HUMAN MUCOSAE - INDUCTION AND RELATION TO BACTERIAL RESPIRATORY-TRACT INFECTIONS
    BRANDTZAEG, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 : S167 - S176
  • [8] Dalseg R, 1996, VACCINES, P177
  • [9] DALSEG R, 1995, CLIN IMMUNOL IMMUNOP, V76, pS93
  • [10] Elson Charles O., 1996, P59, DOI 10.1016/B978-012410580-5/50005-4